INTERRELATIONSHIPS BETWEEN HELICOBACTER-PYLORI INFECTION, NONSTEROIDAL ANTIINFLAMMATORY DRUGS AND GASTRODUODENAL DISEASE - A PROSPECTIVE-STUDY IN HEALTHY-VOLUNTEERS

被引:52
作者
THILLAINAYAGAM, AV
TABAQCHALI, S
WARRINGTON, SJ
FARTHING, MJG
机构
[1] UNIV LONDON ST BARTHOLOMEWS HOSP & MED COLL, DEPT GASTROENTEROL, LONDON EC1A 7BE, ENGLAND
[2] UNIV LONDON ST BARTHOLOMEWS HOSP & MED COLL, DEPT CLIN PHARMACOL, LONDON EC1A 7BE, ENGLAND
[3] UNIV LONDON ST BARTHOLOMEWS HOSP & MED COLL, DEPT MICROBIOL, LONDON EC1A 7BE, ENGLAND
关键词
HELICOBACTER PYLORI; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; GASTRODUODENAL MUCOSAL INJURY;
D O I
10.1007/BF02087562
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Helicobacter pylori and nonsteroidal antiinflammatory drugs independently cause gastroduodenal mucosal injury but the relationship between them remains unclear. We have performed a double-blind, parallel-group, placebo-controlled prospective study in 77 healthy volunteers aged 19-35 years who were randomly allocated to indomethacin (N = 15), one of three oxicams (piroxicam, chlortenoxicam, or CHF 1194; N = 36), or placebo (N = 26). Esophagogastroduodenoscopy was performed before and after four weeks of treatment and the mucosal appearances graded. Colonization with H. pylori was established at each endoscopy and gastrointestinal symptoms ware assessed by daily diary card. Seven subjects (9%) were positive for H. pylori before treatment (one placebo, one indomethacin, and five an oxicam); their H. pylori status remained unchanged. Two of 70 H. pylori-negative subjects became H. pylori-positive (2.9%), both of whom had received placebo. The endoscopic score deteriorated in 1/6 drug-treated H. pylori-positive subjects and in 0/1 taking placebo. Of the H. pylori-negative subjects whose endoscopic score deteriorated, three (13%) were taking placebo, four (28.6%) indomethacin, and eight (25.8%) an oxicam. Upper gastrointestinal symptoms were reported in eight (30.8%) of the subjects taking placebo (one subject negative for H. pylori became positive), eight (53.3%) indomethacin (one H. pylori-positive), and 10 (27.8%) an oxicam (one H. pylori-positive). There were no statistically significant differences between the H. pylori-negative and H. pylori-positive groups whether on drug or placebo. These findings suggest that H. pylori infection, at least in the short term, neither influences the propensity of nonsteroidal antiinflammatory drugs to produce macroscopic gastroduodenal mucosal injury nor does it effect the occurrence of upper gastrointestinal symptoms.
引用
收藏
页码:1085 / 1089
页数:5
相关论文
共 31 条
[1]   UTILIZATION OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS [J].
BAUM, C ;
KENNEDY, DL ;
FORBES, MB .
ARTHRITIS AND RHEUMATISM, 1985, 28 (06) :686-692
[2]   A COMPARISON OF THE EFFECTS OF HP 549 (ISOXEPAC), INDOMETHACIN AND ACETYLSALICYLIC-ACID (ASPIRIN) ON GASTRIC-MUCOSA IN MAN [J].
BOSVENDSEN, L ;
HANSEN, OH ;
JOHANSEN, A .
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1981, 10 (03) :186-188
[3]  
COLLINS AJ, 1988, BRIT J RHEUMATOL, V27, P106
[4]   PREVALENCE OF HELICOBACTER-PYLORI INFECTION AND HISTOLOGIC GASTRITIS IN ASYMPTOMATIC PERSONS [J].
DOOLEY, CP ;
COHEN, H ;
FITZGIBBONS, PL ;
BAUER, M ;
APPLEMAN, MD ;
PEREZPEREZ, GI ;
BLASER, MJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (23) :1562-1566
[5]  
DOUBE A, 1988, BRIT J RHEUMATOL, V27, P110
[6]   EFFECT OF AGE ON THE FREQUENCY OF ACTIVE CAMPYLOBACTER-PYLORI INFECTION DIAGNOSED BY THE [C-13] UREA BREATH TEST IN NORMAL SUBJECTS AND PATIENTS WITH PEPTIC-ULCER DISEASE [J].
GRAHAM, DY ;
KLEIN, PD ;
OPEKUN, AR ;
BOUTTON, TW .
JOURNAL OF INFECTIOUS DISEASES, 1988, 157 (04) :777-780
[7]   EPIDEMIOLOGY OF HELICOBACTER-PYLORI IN AN ASYMPTOMATIC POPULATION IN THE UNITED-STATES - EFFECT OF AGE, RACE, AND SOCIOECONOMIC-STATUS [J].
GRAHAM, DY ;
MALATY, HM ;
EVANS, DG ;
EVANS, DJ ;
KLEIN, PD ;
ADAM, E .
GASTROENTEROLOGY, 1991, 100 (06) :1495-1501
[8]   LONG-TERM NONSTEROIDAL ANTIINFLAMMATORY DRUG-USE AND HELICOBACTER-PYLORI INFECTION [J].
GRAHAM, DY ;
LIDSKY, MD ;
COX, AM ;
EVANS, DJ ;
EVANS, DG ;
ALPERT, L ;
KLEIN, PD ;
SESSOMS, SL ;
MICHALETZ, PA ;
SAEED, ZA .
GASTROENTEROLOGY, 1991, 100 (06) :1653-1657
[9]   CAMPYLOBACTER-PYLORI AND PEPTIC-ULCER DISEASE [J].
GRAHAM, DY .
GASTROENTEROLOGY, 1989, 96 (02) :615-625
[10]  
GRAHAM DY, 1988, AM J GASTROENTEROL, V83, P1081